CW
VRTX icon

CIC Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

CIC Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.51M Buy
3,237
+65
+2% +$31.2K 0.39% 57
2024
Q2 		$1.49M Sell
3,172
-250
-7% -$109K 0.41% 52
2024
Q1 		$1.43M Buy
3,422
+734
+27% +$310K 0.42% 55
2023
Q4 		$1.09M Buy
+2,688
New +$993K 0.35% 61

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CIC Wealth's VRTX Position: Q3 2024 in Review

CIC Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 2% in Q3 2024, buying an estimated $31.2K and bringing the position to 3,237 shares worth $1.51M. The position accounts for 0.39% of the portfolio, ranked #57.

CIC Wealth first reported a position in VRTX in Q4 2023 and has held it in 4 quarters since. 1,547 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • CIC Wealth held 3,237 shares of Vertex Pharmaceuticals worth $1.51M as of Q3 2024.
  • CIC Wealth bought 65 Vertex Pharmaceuticals shares in Q3 2024, an estimated $31.2K.
  • Vertex Pharmaceuticals made up 0.39% of CIC Wealth's portfolio in Q3 2024, its #57 holding.
  • CIC Wealth first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • 1,547 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.